Reply to "Comment on 'Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson's Disease via Oral Gavage'".

Xu, Kai; Huang, Peng; Peng, Yongbo; Qu, Shaogang

Xu, Kai; Huang, Peng; Peng, Yongbo; Qu, Shaogang.

Afiliação

Xu K; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, People's Republic of China.
Huang P; Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangzhou, Guangdong 510515, People's Republic of China.
Peng Y; Key Laboratory of Mental Health of the Ministry of Education, Southern Medical University, Guangzhou, Guangdong 510515, People's Republic ofChina.
Qu S; Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, People's Republic of China.

ACS Nano ; 18(18): 11489-11491, 2024 May 07.

Article em En | MEDLINE | ID: mdl-38712356

Assuntos

Nanopartículas; Doença de Parkinson; Selênio; Selênio/química; Selênio/farmacologia; Humanos; Doença de Parkinson/tratamento farmacológico; Nanopartículas/química; Administração Oral; Albumina Sérica Humana/química

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Selênio / Nanopartículas Limite: Humans Idioma: En Revista: ACS Nano / ACS nano Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google